Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

52.80p
   
  • Change Today:
    -1.30p
  • 52 Week High: 88.50
  • 52 Week Low: 50.80
  • Currency: UK Pounds
  • Shares Issued: 968.12m
  • Volume: 8,791,465
  • Market Cap: £511.17m
  • Beta: 0.01

Dr. Martens Overview

Dr. Martens operates in the global footwear market. Statista estimates that global retail sales of footwear in 2019 were £341 billion representing 12 billion pairs of footwear. Dr. Martens has a diversified global presence, with sales in more than 60 countries. The Group’s current geographical footprint, in terms of total Group revenue, is more weighted towards the US and EMEA, with APAC representing 20% of Dr. Martens’ FY20 revenue as compared to 29% for retail sales of the entire footwear market.

Key Personnel

CEO: Ije Nwokori
CFO: Giles Wilson
Chairman: Paul Mason
Independent Non-Executive Director: Robyn Perriss
Independent Non-Executive Director: Ian Rogers
Independent Non-Executive Director: Andrew Harrison
Independent Non-Executive Director: Alia Gogi
Senior Independent Director: Melanie Richards
Non-Executive Dir: Tara Alhadef, Robert Hanson , Benoit Vauchy

Contact Details

Address: 28 Jamestown Road, Camden, London, United Kingdom, NW1 7BY
Website: http://www.drmartensplc.com

Listings

Sector: Personal Goods(LSE)
Index: FTSE 250, FTSE 350, FTSE All-Share
ISIN: GB00BL6NGV24

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 52.80p
Change Today -1.30p
% Change -2.40 %
52 Week High 88.50
52 Week Low 50.80
Volume 8,791,465
Shares Issued 968.12m
Market Cap £511.17m
Beta 0.01

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
49.49% below the market average49.49% below the market average49.49% below the market average49.49% below the market average49.49% below the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average
Price Trend
55.09% below the market average55.09% below the market average55.09% below the market average55.09% below the market average55.09% below the market average
84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average
Income
18.74% above the market average18.74% above the market average18.74% above the market average18.74% above the market average18.74% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
13.56% above the market average13.56% above the market average13.56% above the market average13.56% above the market average13.56% above the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

Dr. Martens Dividends

  Latest Previous
  Interim Final
Ex-Div 04-Mar-27 27-Aug-26
Paid 07-Apr-27 07-Oct-26
Amount 0.85p 1.70p

Trades for 13-Nov-2026

Time Volume / Share Price
16:35 3,527 @ 52.80p
16:35 6,079 @ 52.80p
16:35 636,129 @ 52.80p
16:35 1 @ 52.80p
16:35 1,690 @ 52.80p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Ije Nwokori
CFO Giles Wilson

Top of Page